http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#Head
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#assertion
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#provenance
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#pubinfo
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#assertion
http://purl.obolibrary.org/obo/DOID_8534
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_8534
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00213
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
http://www.w3.org/2000/01/rdf-schema#label
pantoprazole sodium delayed release tablets are indicated for pantoprazole sodium delayed release tablet is a proton pump inhibitor indicated for the following short term treatment of erosive esophagitis associated with gastroesophageal reflux disease gerd 1 1 maintenance of healing of erosive esophagitis 1 2 pathological hypersecretory conditions including zollinger ellison syndrome 1 3 pantoprazole sodium delayed release tablets are indicated in adults for the short term treatment up to 8 weeks in the healing and symptomatic relief of erosive esophagitis for those adult patients who have not healed after 8 weeks of treatment an additional 8 week course of pantoprazole sodium delayed release tablets may be considered safety of treatment beyond 8 weeks in pediatric patients has not been established pediatric indication and usage information in pediatric patients ages five years and older with erosive esophagitis associated with gerd is approved for wyeth pharmaceuticals inc s pantoprazole sodium delayed release tablets however due to wyeth pharmaceuticals inc s marketing exclusivity rights this drug product is not labeled with that pediatric information pantoprazole sodium delayed release tablets are indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd controlled studies did not extend beyond 12 months pantoprazole sodium delayed release tablets are indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB00213
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#provenance
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#pubinfo
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#sig
http://purl.org/nanopub/x/hasSignature
i4kRDrq1LOQ1QpYTlEOP85ZmeYZsMoxubaENG2De4rODOv43mRvoqA6W2uPL2uUHI1HYKkoes8n7bt9+29ikxo9CyV8xQNSH+5b9lqfb4+9klZ8B1k4RkGDNO6VqLvYjSHSi66vIwhTYbUZlDx2gjmshl5qPTrG69SJgcSo2074=
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://purl.org/dc/terms/created
2021-06-28T08:53:08.231+02:00
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAcnhAgYVf9i2-hg3CbrnOu8f4mChlQKgmQboEieGbxJk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs